Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%
terminated125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

The Validation Study of Bioelectronics

NCT05397951
completed

Accuracy Assessment of Beddr Oximeter

NCT03710993
completed

Accuracy of Pulse Oximeters With Profound Hypoxia

NCT03710980
terminated

Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer

NCT00568360

Clinical Trials (4)

Showing 4 of 4 trials
NCT05397951Not Applicable

The Validation Study of Bioelectronics

Recruiting
NCT03710993

Accuracy Assessment of Beddr Oximeter

Completed
NCT03710980

Accuracy of Pulse Oximeters With Profound Hypoxia

Completed
NCT00568360

Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4